Form 4: Cormorant Asset Management Acquires Additional Shares in Bright Minds Biosciences Inc.

Cormorant Asset Management, LP reports the acquisition of 184,331 common shares of Bright Minds Biosciences Inc. at $21.7 per share, increasing its total indirect holdings to 1,059,331 shares.

Summary

• On November 4, 2024, Cormorant Asset Management, LP acquired 184,331 common shares of Bright Minds Biosciences Inc. at a price of $21.7 per share.
• Following this transaction, Cormorant's indirect beneficial ownership in Bright Minds Biosciences Inc. increased to 1,059,331 shares.
• The shares are held for the account of Cormorant Global Healthcare Master Fund, LP, for which Cormorant Asset Management, LP serves as the investment manager.
• Bihua Chen, as the managing member of Cormorant Global Healthcare GP, LLC and the general partner of Cormorant, has signed the Form 4 on behalf of Cormorant Asset Management, LP.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a transaction without expressing a strong positive or negative view on the company's prospects. The increased investment could be seen as a positive, but the filing itself is simply a reporting requirement.

Positives

• The increased investment by Cormorant Asset Management, LP could be seen as a positive signal for Bright Minds Biosciences Inc.

Industry Context

This filing reflects investment activity in the biotechnology sector, specifically in a company focused on developing novel therapeutics for mental health disorders.

Stakeholder Impact

• Shareholders may view the increased investment by Cormorant Asset Management, LP positively.

Key Dates